Pulmonx Corporation (LUNG) vs Myomo, Inc. (MYO)
Pulmonx Corporation and Myomo, Inc. are both Medical Devices companies. Pulmonx Corporation is the larger, with a market value of $81.6M against $64.6M — 1.3× the size. Myomo, Inc. grew revenue faster over the last twelve months: 6.14% against −3.43%. Myomo, Inc. has the higher net margin (−33.5% vs −55.0%) and the lower return on invested capital (−167.9% vs −141.0%). Across the 18 metrics below, Pulmonx Corporation leads on 10 and Myomo, Inc. on 8.
Valuation
Profitability
| Metric | LUNG | MYO | Medical Devices median |
|---|---|---|---|
| Gross margin | 77.06% | 68.35% | 56.01% |
| Operating margin | (52.96%) | (27.05%) | (15.03%) |
| Net margin | (55.03%) | (33.53%) | (20.40%) |
| Free cash flow margin | (35.07%) | (21.01%) | (7.24%) |
| Return on equity | (88.87%) | (123.76%) | (15.32%) |
| Return on assets | (36.74%) | (39.20%) | (19.72%) |
| Return on invested capital | (141.03%) | (167.90%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack